Growth Metrics

Bio-Rad Laboratories (BIO) Net Cash Flow Growth (3y) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCF Growth (3y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -32.51%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -87.87%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 42.74%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -11.49%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -87.88%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -48.90%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 129.29%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -65.12%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 33.47%
10 Bio-Rad Laboratories 8.23 Bn 6.66 Bn 309.40 Mn -42.78%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -42.78%
Dec 31, 2025 59.33%
Sep 30, 2025 31.90%
Jun 30, 2025 13.99%
Mar 31, 2025 -52.36%
Dec 31, 2024 29.51%
Sep 30, 2024 -55.33%
Jun 30, 2024 -36.13%
Mar 31, 2024 14.18%
Dec 31, 2023 36.75%
Sep 30, 2023 -35.25%
Jun 30, 2023 -414.94%
Mar 31, 2023 38.60%
Dec 31, 2022 -39.22%
Sep 30, 2022 -80.72%
Jun 30, 2022 -54.73%
Mar 31, 2022 144.00%
Dec 31, 2021 -399.54%
Sep 30, 2021 63.40%
Jun 30, 2021 109.16%
Mar 31, 2021 -9.31%
Dec 31, 2020 -72.47%
Sep 30, 2020 175.78%
Jun 30, 2020 -71.31%
Mar 31, 2020 33.76%
Dec 31, 2019 25.48%
Sep 30, 2019 -149.79%
Jun 30, 2019 81.89%
Mar 31, 2019 33.61%
Dec 31, 2018 27.50%
Sep 30, 2018 -18.81%
Jun 30, 2018 -37.20%
Mar 31, 2018 177.60%
Dec 31, 2017 133.03%
Sep 30, 2017 -38.23%
Jun 30, 2017 5.28%
Mar 31, 2017 -90.88%
Dec 31, 2016 10.88%
Sep 30, 2016 26.28%
Jun 30, 2016 81.12%
Mar 31, 2016 14.13%
Dec 31, 2015 -51.31%
Sep 30, 2015 57.46%
Jun 30, 2015 29.77%
Mar 31, 2015 26.49%
Dec 31, 2014 60.72%
Sep 30, 2014 169.91%
Jun 30, 2014 -12.01%
Mar 31, 2014 28.52%
Dec 31, 2013 -49.46%
Sep 30, 2013 -123.82%
Jun 30, 2013 -33.74%
Mar 31, 2013 -19.51%
Dec 31, 2012 -31.76%
Sep 30, 2012 -57.01%